Get started
Author

Biswajit Das

ORCID: 0009-0009-7976-791X
Observed ORCIDs: 0009-0009-7976-791X, 0000-0002-5193-2049
OpenAlex ID: A5101438321
Anticancer efficacy of noble metal nanoparticles relies on reprogramming tumor-associated macrophages through redox pathways and pro-inflammatory cytokine cascades
2018 · Mahuya Sengupta, Ramkrishna Pal, et al. · Cellular and Molecular Immunology · 23
Synthesis and Characterization of Arsenic(III) Oxide Nanoparticles as Potent Inhibitors of MCF 7 Cell Proliferation through Proapoptotic Mechanism
2020 · Biswajit Das, Hasimur Rahaman, et al. · BioNanoScience · 12
Tumor histoculture captures the dynamic interactions between tumor and immune components in response to anti-PD1 in head and neck cancer
2024 · Nandini Pal Basak, Kowshik Jaganathan, et al. · Nature Communications · 10
PDF
Sphingosine-1-phosphate promotes CD8 T cell exhaustion in breast cancer via exosomal transfer of TGFBR2
2026 · Avinandan Bhoumick, Arnab Ghosh, et al. · Cell Death and Disease · 3
Alteration in Inflammasome Cytokine Profile and Functional Plasticity of Macrophage Phenotype in Arsenic(0) Nanoparticle Treated Murine Fibrosarcoma
2022 · Biswajit Das, Anjali Pal, et al. · BioNanoScience · 1
Thrombin-PAR1 signaling regulates Topoisomerase 1 activity to bridge inflammation and breast cancer progression
2026 · Abhishek Roy, Arnab Ghosh, et al. · Cancer Letters
Abstract 6549: Integrating functional biosignatures and same-cell spatial multiomics to predict synergistic benefit of combination checkpoint therapy in head and neck cancer
2026 · Yi Cui, Moumita Nath, et al. · Cancer Research
Abstract 7761: Tertiary lymphoid structure (TLS) representative cells elicit response to anti-PD-1+ therapy in a cold tumor
2026 · Satish Sankaran, Priyanka Chevour, et al. · Cancer Research
475 Understanding the role of tumor immune microenvironment in determining response to immune checkpoint inhibitor in colorectal cancer
2025 · Satish Sankaran, M Dharanidharan, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 5807: Differential T cell response to anti-PD1 in breast cancer Sub-types is driven by activity of intra-tumoral immune cells
2025 · Mouniss MM, Biswajit Das, et al. · Cancer Research
Abstract B030: Identification of tumor microenvironment informed exosome biomarkers for predicting response to anti-PD1 therapy
2025 · Kowshik Jaganathan, Moumita Nath, et al. · Cancer Research
Abstract 3843: Role of CD4/CD8 double positive T cells in modulating response to anti-PD-1 treatment in renal cell carcinoma
2024 · Satish Sankaran, Kowshik Jaganathan, et al. · Cancer Research
Abstract A018: Characterization of macrophage population in head and neck squamous cell carcinoma and renal cell carcinoma and their role in modulating immune checkpoint blockade response
2023 · Moumita Nath, Nandini Pal Basak, et al. · Cancer Immunology Research
1104 Identification of effective treatment regimens for ovarian cancer using tumor histoculture platform
2023 · Biswajit Das, Kowshik Jaganathan, et al. · Journal for ImmunoTherapy of Cancer
PDF
462 Pre-selection of patients who would respond to combination of chemotherapy and low dose immunotherapy using human histoculture platform
2023 · Kowshik Jaganathan, Biswajit Das, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 4568: Evaluating response of renal cell carcinoma to tyrosine kinase inhibitor and immune checkpoint inhibitor using a human histo-culture platform
2023 · Satish Sankaran, Kowshik Jaganathan, et al. · Cancer Research
Abstract 6632: Simultaneous comparison of response to two different anti-PD1 drugs in the same patient using a human tumor histo-culture platform
2023 · Satish Sankaran, Biswajit Das, et al. · Cancer Research
142 Demonstrating the role of spatial contexture in determining response to immune check point inhibitors using a tumor histoculture platform
2022 · Satish Sankaran, Oliyarasi M, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 3385: Comparison of genomic biomarkers identified by the whole exome, RNASeq and whole genome sequencing pipelines developed for the PDMR
2019 · Li Chen, Rajesh Patidar, et al. · Cancer Research
Works count: 19
Citation count: 49
H-index: 3
I10-index: 3
Year
Topic
Type